{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:14:35Z","timestamp":1790673275681,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"\u201cPersonalized Medicines\u2014\u2014Molecular Signature-based Drug Discovery and Development\u201d, Strategic Priority Research Program of the Chinese Academy of Sciences","award":["XDA12020113"],"award-info":[{"award-number":["XDA12020113"]}]},{"name":"Science & Technology Commission of Shanghai Municipality, China","award":["18431907100"],"award-info":[{"award-number":["18431907100"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Systemic sclerosis is a multisystem inflammatory and vascular lesion leading to extensive tissue fibrosis. A reversible S-adenosyl-l-homocysteine hydrolase (SAHH) inhibitor, DZ2002, modulates the pathologic processes of various inflammatory diseases and autoimmune diseases. This study is designed to investigate the therapeutic potentiality of DZ2002 for experimental systemic sclerosis models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The anti-inflammatory and anti-fibrotic features of DZ2002 and its mechanisms were investigated in a bleomycin (BLM)-induced dermal fibrosis mice model. The effects of DZ2002 on expression of extracellular matrix components and TGF-\u03b2 signaling in human dermal fibroblasts were analyzed. Simultaneously, the effects of DZ2002 on macrophage activation and endothelial cell adhesion molecule expression were also evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>DZ2002 significantly attenuated dermal fibrosis in BLM-induced mice. Consistently, DZ2002 inhibited the expression of various molecules associated with dermal fibrosis, including transforming growth factor \u03b21, connective tissue growth factor, tumor necrosis factor-\u03b1, interferon-\u03b3, IL-1\u03b2, IL-4, IL-6, IL-10, IL-12p40, IL-17A, and monocyte chemotactic protein 1 in the lesional skin of BLM-induced mice. Furthermore, DZ2002 decreased the proportion of macrophages, neutrophils, and T cells (especially T helper cells) in the skin tissue of BLM-induced mice. In addition, DZ2002 attenuated both M1 macrophage and M2 macrophage differentiation in vivo and in vitro. Importantly, DZ2002 directly reversed the profibrotic phenotype of transforming growth factor-\u03b21-treated dermal fibroblasts and suppressed ICAM-1, VCAM-1, VEGF, bFGF, and ET-1 expression in endothelial cells. Finally, our investigations showed that DZ2002 relieved systemic sclerosis by regulating fibrosis TGF-\u03b2\/Smad signaling pathway.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>DZ2002 prevents the development of experimental dermal fibrosis by reversing the profibrotic phenotype of various cell types and would be a potential drug for the treatment of systemic sclerosis.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13075-019-2074-9","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T19:03:26Z","timestamp":1576523006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["DZ2002 ameliorates fibrosis, inflammation, and vasculopathy in experimental systemic sclerosis models"],"prefix":"10.1186","volume":"21","author":[{"given":"Zongwang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2662-217X","authenticated-orcid":false,"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,16]]},"reference":[{"key":"2074_CR1","doi-asserted-by":"publisher","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP, Varga J. Systemic sclerosis. Nature Reviews Disease Primers. 2015;1:15002.","journal-title":"Nature Reviews Disease Primers"},{"issue":"4 Suppl 92","key":"2074_CR2","first-page":"S3","volume":"33","author":"CP Denton","year":"2015","unstructured":"Denton CP. Systemic sclerosis: from pathogenesis to targeted therapy. Clin Exp Rheumatol. 2015;33(4 Suppl 92):S3\u20137.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"2074_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrrheum.2011.149","volume":"8","author":"S Bhattacharyya","year":"2012","unstructured":"Bhattacharyya S, Wei J, Varga J. Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nat Rev Rheumatol. 2012;8(1):42\u201354.","journal-title":"Nat Rev Rheumatol"},{"key":"2074_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.imlet.2017.11.003","volume":"195","author":"AJ Affandi","year":"2018","unstructured":"Affandi AJ, Carvalheiro T, Radstake T, Marut W. Dendritic cells in systemic sclerosis: advances from human and mice studies. Immunol Lett. 2018;195:18\u201329.","journal-title":"Immunol Lett"},{"issue":"1","key":"2074_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13075-018-1534-y","volume":"20","author":"VH Luong","year":"2018","unstructured":"Luong VH, Chino T, Oyama N, Matsushita T, Sasaki Y, Ogura D, Niwa SI, Biswas T, Hamasaki A, Fujita M, et al. Blockade of TGF-beta\/Smad signaling by the small compound HPH-15 ameliorates experimental skin fibrosis. Arthritis Res Ther. 2018;20(1):46.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"2074_CR6","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1186\/s13075-014-0512-2","volume":"16","author":"M Liu","year":"2014","unstructured":"Liu M, Yang J, Xing X, Cui X, Li M. Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway. Arthritis Res Ther. 2014;16(6):4223.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"2074_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cellimm.2009.12.009","volume":"261","author":"G Slobodin","year":"2010","unstructured":"Slobodin G, Ahmad MS, Rosner I, Peri R, Rozenbaum M, Kessel A, Toubi E, Odeh M. Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity. Cell Immunol. 2010;261(2):77\u201380.","journal-title":"Cell Immunol"},{"issue":"5","key":"2074_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/ar3167","volume":"12","author":"RB Christmann","year":"2010","unstructured":"Christmann RB, Lafyatis R. The cytokine language of monocytes and macrophages in systemic sclerosis. Arthritis Res Ther. 2010;12(5):146.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"2074_CR9","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/nri1733","volume":"5","author":"S Gordon","year":"2005","unstructured":"Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5(12):953\u201364.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"2074_CR10","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1161\/ATVBAHA.108.180497","volume":"29","author":"A Mantovani","year":"2009","unstructured":"Mantovani A, Garlanda C, Locati M. Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler Thromb Vasc Biol. 2009;29(10):1419\u201323.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"2074_CR11","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8(12):958\u201369.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2074_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","volume":"162","author":"JM Fletcher","year":"2010","unstructured":"Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KH. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol. 2010;162(1):1\u201311.","journal-title":"Clin Exp Immunol"},{"key":"2074_CR13","doi-asserted-by":"crossref","unstructured":"Hu D, Notarbartolo S: Transcriptional signature of human pro-inflammatory TH17 cells identifies reduced IL10 gene expression in multiple sclerosis. Nature Communications. 2017;8(1):1600.","DOI":"10.1038\/s41467-017-01571-8"},{"issue":"9","key":"2074_CR14","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1002\/art.11129","volume":"48","author":"C Chizzolini","year":"2003","unstructured":"Chizzolini C, Parel Y, De Luca C, Tyndall A, Akesson A, Scheja A, Dayer JM. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha. Arthritis Rheum. 2003;48(9):2593\u2013604.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2074_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.clim.2011.01.013","volume":"139","author":"D Fenoglio","year":"2011","unstructured":"Fenoglio D, Battaglia F, Parodi A, Stringara S, Negrini S, Panico N, Rizzi M, Kalli F, Conteduca G, Ghio M, et al. Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis. Clin Immunol. 2011;139(3):249\u201357.","journal-title":"Clin Immunol"},{"issue":"8","key":"2074_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012106","volume":"5","author":"SA Pendergrass","year":"2010","unstructured":"Pendergrass SA, Hayes E, Farina G, Lemaire R, Farber HW, Whitfield ML, Lafyatis R. Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury. PLoS One. 2010;5(8):e12106.","journal-title":"PLoS One"},{"issue":"12","key":"2074_CR17","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1002\/art.1780331214","volume":"33","author":"BW Needleman","year":"1990","unstructured":"Needleman BW. Increased expression of intercellular adhesion molecule 1 on the fibroblasts of scleroderma patients. Arthritis Rheum. 1990;33(12):1847\u201351.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2074_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000163881","volume":"62","author":"MM Cho","year":"1994","unstructured":"Cho MM, Jimenez SA, Johnson BA, Harlow LA, Burrows JC, Koch AE. In vitro cytokine modulation of intercellular adhesion molecule-1 expression on systemic sclerosis dermal fibroblasts. Pathobiol. 1994;62(2):73\u201381.","journal-title":"Pathobiol"},{"issue":"7","key":"2074_CR19","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/rheumatology\/kep091","volume":"48","author":"BJ Rabquer","year":"2009","unstructured":"Rabquer BJ, Hou Y, Del Galdo F, Kenneth Haines G 3rd, Gerber ML, Jimenez SA, Seibold JR, Koch AE. The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1. Rheumatol. 2009;48(7):734\u201340.","journal-title":"Rheumatol"},{"issue":"6","key":"2074_CR20","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/art.1780400602","volume":"40","author":"CF Mojcik","year":"1997","unstructured":"Mojcik CF, Shevach EM. Adhesion molecules: a rheumatologic perspective. Arthritis Rheum. 1997;40(6):991\u20131004.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2074_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1089\/107999099314234","volume":"19","author":"G Krishnaswamy","year":"1999","unstructured":"Krishnaswamy G, Kelley J, Yerra L, Smith JK, Chi DS. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res. 1999;19(2):91\u2013104.","journal-title":"J Interferon Cytokine Res"},{"issue":"18","key":"2074_CR22","doi-asserted-by":"crossref","first-page":"10997","DOI":"10.1016\/S0021-9258(17)44376-6","volume":"258","author":"DC German","year":"1983","unstructured":"German DC, Bloch CA, Kredich NM. Measurements of S-adenosylmethionine and L-homocysteine metabolism in cultured human lymphoid cells. J Biol Chem. 1983;258(18):10997\u20131003.","journal-title":"J Biol Chem"},{"issue":"4","key":"2074_CR23","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1096\/fasebj.10.4.8647346","volume":"10","author":"PK Chiang","year":"1996","unstructured":"Chiang PK, Gordon RK, Tal J, Zeng GC, Doctor BP, Pardhasaradhi K, McCann PP. S-Adenosylmethionine and methylation. FASEB J. 1996;10(4):471\u201380.","journal-title":"FASEB J"},{"issue":"2","key":"2074_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.clim.2013.02.018","volume":"147","author":"V Tardif","year":"2013","unstructured":"Tardif V, Manenkova Y, Berger M, Hoebe K, Zuo JP, Yuan C, Kono DH, Theofilopoulos AN, Lawson BR. Critical role of transmethylation in TLR signaling and systemic lupus erythematosus. Clin Immunol. 2013;147(2):133\u201343.","journal-title":"Clin Immunol"},{"issue":"2","key":"2074_CR25","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1124\/jpet.106.107185","volume":"319","author":"YF Fu","year":"2006","unstructured":"Fu YF, Zhu YN, Ni J, Zhong XG, Tang W, Re YD, Shi LP, Wan J, Yang YF, Yuan C, et al. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation. J Pharmacol Exp Ther. 2006;319(2):799\u2013808.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"2074_CR26","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1124\/jpet.104.080416","volume":"313","author":"QL Wu","year":"2005","unstructured":"Wu QL, Fu YF, Zhou WL, Wang JX, Feng YH, Liu J, Xu JY, He PL, Zhou R, Tang W, et al. Inhibition of S-adenosyl-L-homocysteine hydrolase induces immunosuppression. J Pharmacol Exp Ther. 2005;313(2):705\u201311.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"2074_CR27","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1124\/jpet.105.093369","volume":"316","author":"YF Fu","year":"2006","unstructured":"Fu YF, Wang JX, Zhao Y, Yang Y, Tang W, Ni J, Zhu YN, Zhou R, He PL, Li C, et al. S-adenosyl-L-homocysteine hydrolase inactivation curtails ovalbumin-induced immune responses. J Pharmacol Exp Ther. 2006;316(3):1229\u201337.","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"2074_CR28","doi-asserted-by":"publisher","first-page":"5366","DOI":"10.4049\/jimmunol.178.8.5366","volume":"178","author":"BR Lawson","year":"2007","unstructured":"Lawson BR, Manenkova Y, Ahamed J, Chen X, Zou JP, Baccala R, Theofilopoulos AN, Yuan C. Inhibition of transmethylation down-regulates CD4 T cell activation and curtails development of autoimmunity in a model system. J Immunol. 2007;178(8):5366\u201374.","journal-title":"J Immunol"},{"issue":"1","key":"2074_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13075-019-1820-3","volume":"21","author":"S He","year":"2019","unstructured":"He S, Liu X, Lin Z, Liu Y, Gu L, Zhou H, Tang W, Zuo J. Reversible SAHH inhibitor protects against glomerulonephritis in lupus-prone mice by downregulating renal alpha-actinin-4 expression and stabilizing integrin-cytoskeleton linkage. Arthritis Res Ther. 2019;21(1):40.","journal-title":"Arthritis Res Ther"},{"key":"2074_CR30","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.phrs.2017.11.012","volume":"129","author":"ZM Lin","year":"2018","unstructured":"Lin ZM, Ma M, Li H, Qi Q, Liu YT, Yan YX, Shen YF, Yang XQ, Zhu FH, He SJ, et al. Topical administration of reversible SAHH inhibitor ameliorates imiquimod-induced psoriasis-like skin lesions in mice via suppression of TNF-alpha\/IFN-gamma-induced inflammatory response in keratinocytes and T cell-derived IL-17. Pharmacol Res. 2018;129:443\u201352.","journal-title":"Pharmacol Res"},{"issue":"6","key":"2074_CR31","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/1523-1747.ep12613748","volume":"99","author":"EW Ades","year":"1992","unstructured":"Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol. 1992;99(6):683\u201390.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"2074_CR32","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/jcp.22891","volume":"227","author":"C Sun","year":"2012","unstructured":"Sun C, Sun L, Ma H, Peng J, Zhen Y, Duan K, Liu G, Ding W, Zhao Y. The phenotype and functional alterations of macrophages in mice with hyperglycemia for long term. J Cell Physiol. 2012;227(4):1670\u20139.","journal-title":"J Cell Physiol"},{"issue":"6","key":"2074_CR33","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/art.37933","volume":"65","author":"DL Huu","year":"2013","unstructured":"Huu DL, Matsushita T, Jin G, Hamaguchi Y, Hasegawa M, Takehara K, Fujimoto M. FTY720 ameliorates murine sclerodermatous chronic graft-versus-host disease by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into skin. Arthritis Rheum. 2013;65(6):1624\u201335.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2074_CR34","first-page":"S624","volume":"50","author":"S Chujo","year":"2004","unstructured":"Chujo S, Shirasaki F, Kinbara T, Takehara K, Kawara S, Inagaki Y. Connective tissue growth factor causes persistent proa2(I) collagen gene expression induced by transforming growth factor-b in a mouse fibrosis model. Arthritis Rheum. 2004;50(9):S624\u20135.","journal-title":"Arthritis Rheum"},{"key":"2074_CR35","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.1038\/ncomms6797","volume":"5","author":"S Noda","year":"2014","unstructured":"Noda S, Asano Y, Nishimura S, Taniguchi T, Fujiu K, Manabe I, Nakamura K, Yamashita T, Saigusa R, Akamata K, et al. Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis. Nat Commun. 2014;5:5797.","journal-title":"Nat Commun"},{"issue":"2","key":"2074_CR36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2353\/ajpath.2006.041306","volume":"168","author":"Y Asano","year":"2006","unstructured":"Asano Y, Ihn H, Yamane K, Jinnin M, Tamaki K. Increased expression of integrin alphavbeta5 induces the myofibroblastic differentiation of dermal fibroblasts. Am J Pathol. 2006;168(2):499\u2013510.","journal-title":"Am J Pathol"},{"issue":"4","key":"2074_CR37","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0002-9440(10)63215-4","volume":"164","author":"Y Asano","year":"2004","unstructured":"Asano Y, Ihn H, Yamane K, Kubo M, Tamaki K. Increased expression levels of integrin alphavbeta5 on scleroderma fibroblasts. Am J Pathol. 2004;164(4):1275\u201392.","journal-title":"Am J Pathol"},{"issue":"2","key":"2074_CR38","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/bjd.14183","volume":"174","author":"R Saigusa","year":"2016","unstructured":"Saigusa R, Asano Y, Yamashita T, Taniguchi T, Takahashi T, Ichimura Y, Toyama T, Yoshizaki A, Miyagaki T, Sugaya M, et al. Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions. Br J Dermatol. 2016;174(2):338\u201347.","journal-title":"Br J Dermatol"},{"issue":"11","key":"2074_CR39","doi-asserted-by":"publisher","first-page":"7708","DOI":"10.4049\/jimmunol.175.11.7708","volume":"175","author":"Y Asano","year":"2005","unstructured":"Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, Tamaki K. Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts. J Immunol. 2005;175(11):7708\u201318.","journal-title":"J Immunol"},{"issue":"9","key":"2074_CR40","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1002\/art.21246","volume":"52","author":"Y Asano","year":"2005","unstructured":"Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y, Tamaki K. Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts. Arthritis Rheum. 2005;52(9):2897\u2013905.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2074_CR41","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nri2156","volume":"7","author":"K Ley","year":"2007","unstructured":"Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7(9):678\u201389.","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"2074_CR42","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nri3070","volume":"11","author":"C Shi","year":"2011","unstructured":"Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol. 2011;11(11):762\u201374.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"2074_CR43","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s10067-011-1766-6","volume":"30","author":"VK Shanmugam","year":"2011","unstructured":"Shanmugam VK, Swistowski DR, Saddic N, Wang H, Steen VD. Comparison of indirect immunofluorescence and multiplex antinuclear antibody screening in systemic sclerosis. Clin Rheumatol. 2011;30(10):1363\u20138.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"2074_CR44","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/art.38901","volume":"67","author":"T Takahashi","year":"2015","unstructured":"Takahashi T, Asano Y, Ichimura Y, Toyama T, Taniguchi T, Noda S, Akamata K, Tada Y, Sugaya M, Kadono T, et al. Amelioration of tissue fibrosis by toll-like receptor 4 knockout in murine models of systemic sclerosis. Arthritis Rheumatol. 2015;67(1):254\u201365.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"2074_CR45","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/aps.2013.167","volume":"35","author":"SJ He","year":"2014","unstructured":"He SJ, Lin ZM, Wu YW, Bai BX, Yang XQ, He PL, Zhu FH, Tang W, Zuo JP. Therapeutic effects of DZ2002, a reversible SAHH inhibitor, on lupus-prone NZBxNZW F1 mice via interference with TLR-mediated APC response. Acta Pharmacol Sin. 2014;35(2):219\u201329.","journal-title":"Acta Pharmacol Sin"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-2074-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-2074-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-2074-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T15:09:42Z","timestamp":1613142582000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-2074-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2074"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-2074-9","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"14 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"290"}}